Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹8,927 Cr
Revenue (TTM)
₹1,160 Cr
Net Profit (TTM)
₹237 Cr
ROE
31.6 %
ROCE
42.5 %
P/E Ratio
37.7
P/B Ratio
14.6
Industry P/E
37.76
EV/EBITDA
23.7
Div. Yield
4.8 %
Debt to Equity
0
Book Value
₹367.8
EPS
₹151.5
Face value
10
Shares outstanding
16,599,382
CFO
₹1,235.18 Cr
EBITDA
₹1,931.41 Cr
Net Profit
₹1,392.54 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
| 2.9 | 4.3 | 2.2 | 12.7 | 7.3 | 6.7 | 20.4 |
|
BSE Healthcare
| -6.1 | 0.3 | 7.0 | 18.3 | 22.7 | 22.3 | 9.5 |
|
BSE Small Cap
| -6.3 | 4.5 | 12.0 | 7.1 | 24.9 | 37.3 | 16.4 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
| 5.5 | 25.2 | -26.0 | -23.5 | 54.6 | 38.3 | 133.0 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
|
5,389.5 | 8,927.2 | 1,159.5 | 236.6 | 28.3 | 43.8 | 37.7 | 14.6 |
| 718.7 | 2,087.2 | 451.8 | 50.8 | 11.4 | 16.3 | 41.1 | 6.4 | |
| 466.0 | 7,538.9 | 2,078.3 | 274.4 | 13.0 | 12.5 | 27.5 | 3.2 | |
| 384.3 | 3,815.1 | 809.8 | 82.0 | 15.4 | 14.8 | 46.5 | 6.4 | |
| 529.1 | 3,085.8 | 563.0 | -8.7 | -7.2 | -2.1 | -- | 3.7 | |
| 724.1 | 7,187.6 | 1,247.3 | 92.0 | 16.0 | 4 | 81.4 | 3.0 | |
| 726.0 | 6,731.1 | 4,632.7 | 358.2 | 14.8 | 15 | 1.9 | 2.6 | |
| 719.7 | 5,837.0 | 670.6 | 174.5 | 34.4 | 20.3 | 33.4 | 6.1 | |
| 19.3 | 1,851.8 | 466.0 | 49.4 | 10.7 | 15.1 | 37.5 | 5.4 | |
| 886.8 | 2,033.8 | 759.9 | 61.0 | 8.7 | 12.5 | 33.3 | 4.0 |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its... products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV. Read more
Incorporated
1967
Chairman
Suresh N Talwar
Managing Director
Milind Thatte
Group
Merck - MNC
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Procter & Gamble Health Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Procter & Gamble Health Ltd stood at ₹ 870 Cr as on 31-Dec-24
The share price of Procter & Gamble Health Ltd is ₹5,389.50 (NSE) and ₹5,391.95 (BSE) as of 23-May-2025 10:19 IST. Procter & Gamble Health Ltd has given a return of 7.27% in the last 3 years.
Procter & Gamble Health Ltd has a market capitalisation of ₹ 8,927 Cr as on 23-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Procter & Gamble Health Ltd is 14.62 times as on 23-May-2025, a 170% premium to its peers’ median range of 5.41 times.
The P/E ratio of Procter & Gamble Health Ltd is 37.74 times as on 23-May-2025, a 0% discount to its peers’ median range of 37.76 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Procter & Gamble Health Ltd and enter the required number of quantities and click on buy to purchase the shares of Procter & Gamble Health Ltd.
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
The promoter of Procter & Gamble Health Ltd is PROCTER AND GAMBLE OVERSEAS INDIA B.V.. PROCTER AND GAMBLE OVERSEAS INDIA B.V. owns 51.82 per cent of the total equity. The chairman of the company is Suresh N Talwar , and the managing director is Milind Thatte..
There is no promoter pledging in Procter & Gamble Health Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
7,186
|
|
|
6,919
|
|
|
6,098
|
|
|
5,608
|
|
|
3,812
|
|
|
3,269
|
|
|
2,030
|
|
|
2,006
|
|
|
1,646
|
| Procter & Gamble Health Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
43.77
|
|
Operating margin(%)
|
28.27
|
|
Net Margin(%)
|
20.2
|
|
Dividend yield(%)
|
4.81
|
Yes, TTM profit after tax of Procter & Gamble Health Ltd was ₹237 Cr.
₹-11.50
(
